Global Measles Vaccine Market Research Report 2021

Global Measles Vaccine Market Research Report 2021

Table of Contents
1 Measles Vaccine Market Overview
1.1 Product Overview and Scope of Measles Vaccine
1.2 Measles Vaccine Segment by Type
1.2.1 Global Measles Vaccine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Mumps Measles Rubella Vaccine, Live (MMR-II)
1.2.3 Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
1.3 Measles Vaccine Segment by Application
1.3.1 Measles Vaccine Sales Comparison by Application: (2021-2027)
1.3.2 Children
1.3.3 Adults
1.4 Global Measles Vaccine Market Size Estimates and Forecasts
1.4.1 Global Measles Vaccine Revenue 2016-2027
1.4.2 Global Measles Vaccine Sales 2016-2027
1.4.3 Measles Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027
2 Measles Vaccine Market Competition by Manufacturers
2.1 Global Measles Vaccine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Measles Vaccine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Measles Vaccine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Measles Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Measles Vaccine Market Competitive Situation and Trends
2.5.1 Measles Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Measles Vaccine Players Market Share by Revenue
2.5.3 Global Measles Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Measles Vaccine Retrospective Market Scenario by Region
3.1 Global Measles Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Measles Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Measles Vaccine Market Facts & Figures by Country
3.3.1 North America Measles Vaccine Sales by Country
3.3.2 North America Measles Vaccine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Measles Vaccine Market Facts & Figures by Country
3.4.1 Europe Measles Vaccine Sales by Country
3.4.2 Europe Measles Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Measles Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Measles Vaccine Sales by Region
3.5.2 Asia Pacific Measles Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Measles Vaccine Market Facts & Figures by Country
3.6.1 Latin America Measles Vaccine Sales by Country
3.6.2 Latin America Measles Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Measles Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Measles Vaccine Sales by Country
3.7.2 Middle East and Africa Measles Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Measles Vaccine Historic Market Analysis by Type
4.1 Global Measles Vaccine Sales Market Share by Type (2016-2021)
4.2 Global Measles Vaccine Revenue Market Share by Type (2016-2021)
4.3 Global Measles Vaccine Price by Type (2016-2021)
5 Global Measles Vaccine Historic Market Analysis by Application
5.1 Global Measles Vaccine Sales Market Share by Application (2016-2021)
5.2 Global Measles Vaccine Revenue Market Share by Application (2016-2021)
5.3 Global Measles Vaccine Price by Application (2016-2021)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 GSK Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Sanofi-Pasteur
6.2.1 Sanofi-Pasteur Corporation Information
6.2.2 Sanofi-Pasteur Description and Business Overview
6.2.3 Sanofi-Pasteur Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Sanofi-Pasteur Product Portfolio
6.2.5 Sanofi-Pasteur Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Merck Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Novartis Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Pfizer Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Serum Institute of India
6.6.1 Serum Institute of India Corporation Information
6.6.2 Serum Institute of India Description and Business Overview
6.6.3 Serum Institute of India Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Serum Institute of India Product Portfolio
6.6.5 Serum Institute of India Recent Developments/Updates
6.7 China National Biotech Group
6.6.1 China National Biotech Group Corporation Information
6.6.2 China National Biotech Group Description and Business Overview
6.6.3 China National Biotech Group Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 China National Biotech Group Product Portfolio
6.7.5 China National Biotech Group Recent Developments/Updates
6.8 Bavarian Nordic
6.8.1 Bavarian Nordic Corporation Information
6.8.2 Bavarian Nordic Description and Business Overview
6.8.3 Bavarian Nordic Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Bavarian Nordic Product Portfolio
6.8.5 Bavarian Nordic Recent Developments/Updates
6.9 Emergent Biosolutions
6.9.1 Emergent Biosolutions Corporation Information
6.9.2 Emergent Biosolutions Description and Business Overview
6.9.3 Emergent Biosolutions Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Emergent Biosolutions Product Portfolio
6.9.5 Emergent Biosolutions Recent Developments/Updates
6.10 Medimmune
6.10.1 Medimmune Corporation Information
6.10.2 Medimmune Description and Business Overview
6.10.3 Medimmune Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Medimmune Product Portfolio
6.10.5 Medimmune Recent Developments/Updates
6.11 Johnson & Johnson
6.11.1 Johnson & Johnson Corporation Information
6.11.2 Johnson & Johnson Measles Vaccine Description and Business Overview
6.11.3 Johnson & Johnson Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Johnson & Johnson Product Portfolio
6.11.5 Johnson & Johnson Recent Developments/Updates
6.12 CSL Limited
6.12.1 CSL Limited Corporation Information
6.12.2 CSL Limited Measles Vaccine Description and Business Overview
6.12.3 CSL Limited Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.12.4 CSL Limited Product Portfolio
6.12.5 CSL Limited Recent Developments/Updates
7 Measles Vaccine Manufacturing Cost Analysis
7.1 Measles Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Measles Vaccine
7.4 Measles Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Measles Vaccine Distributors List
8.3 Measles Vaccine Customers
9 Measles Vaccine Market Dynamics
9.1 Measles Vaccine Industry Trends
9.2 Measles Vaccine Growth Drivers
9.3 Measles Vaccine Market Challenges
9.4 Measles Vaccine Market Restraints
10 Global Market Forecast
10.1 Measles Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Measles Vaccine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Measles Vaccine by Type (2022-2027)
10.2 Measles Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Measles Vaccine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Measles Vaccine by Application (2022-2027)
10.3 Measles Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Measles Vaccine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Measles Vaccine by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Measles Vaccine Sales (K MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Measles Vaccine Sales (K MT) Comparison by Application (2021-2027)
Table 3. Global Measles Vaccine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Measles Vaccine Covered in This Study
Table 5. Global Measles Vaccine Sales (K MT) of Key Manufacturers (2016-2021)
Table 6. Global Measles Vaccine Sales Share by Manufacturers (2016-2021)
Table 7. Global Measles Vaccine Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Measles Vaccine Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Measles Vaccine Average Price (USD/MT) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Measles Vaccine Manufacturing Sites and Area Served
Table 11. Manufacturers Measles Vaccine Product Type
Table 12. Global Measles Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Measles Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Measles Vaccine as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Measles Vaccine Sales by Region (2016-2021) & (K MT)
Table 16. Global Measles Vaccine Sales Market Share by Region (2016-2021)
Table 17. Global Measles Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Measles Vaccine Sales by Country (2016-2021) & (K MT)
Table 19. North America Measles Vaccine Sales Market Share by Country (2016-2021)
Table 20. North America Measles Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Measles Vaccine Revenue Market Share by Country (2016-2021)
Table 22. Europe Measles Vaccine Sales by Country (2016-2021) & (K MT)
Table 23. Europe Measles Vaccine Sales Market Share by Country (2016-2021)
Table 24. Europe Measles Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Measles Vaccine Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Measles Vaccine Sales by Region (2016-2021) & (K MT)
Table 27. Asia Pacific Measles Vaccine Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Measles Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Measles Vaccine Revenue Market Share by Region (2016-2021)
Table 30. Latin America Measles Vaccine Sales by Country (2016-2021) & (K MT)
Table 31. Latin America Measles Vaccine Sales Market Share by Country (2016-2021)
Table 32. Latin America Measles Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Measles Vaccine Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Measles Vaccine Sales by Country (2016-2021) & (K MT)
Table 35. Middle East and Africa Measles Vaccine Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Measles Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Measles Vaccine Revenue Market Share by Country (2016-2021)
Table 38. Global Measles Vaccine Sales (K MT) by Type (2016-2021)
Table 39. Global Measles Vaccine Sales Market Share by Type (2016-2021)
Table 40. Global Measles Vaccine Revenue (Million US$) by Type (2016-2021)
Table 41. Global Measles Vaccine Revenue Share by Type (2016-2021)
Table 42. Global Measles Vaccine Price (USD/MT) by Type (2016-2021)
Table 43. Global Measles Vaccine Sales (K MT) by Application (2016-2021)
Table 44. Global Measles Vaccine Sales Market Share by Application (2016-2021)
Table 45. Global Measles Vaccine Revenue (Million US$) by Application (2016-2021)
Table 46. Global Measles Vaccine Revenue Share by Application (2016-2021)
Table 47. Global Measles Vaccine Price (USD/MT) by Application (2016-2021)
Table 48. GSK Corporation Information
Table 49. GSK Description and Business Overview
Table 50. GSK Measles Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 51. GSK Measles Vaccine Product
Table 52. GSK Recent Developments/Updates
Table 53. Sanofi-Pasteur Corporation Information
Table 54. Sanofi-Pasteur Description and Business Overview
Table 55. Sanofi-Pasteur Measles Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 56. Sanofi-Pasteur Measles Vaccine Product
Table 57. Sanofi-Pasteur Recent Developments/Updates
Table 58. Merck Corporation Information
Table 59. Merck Description and Business Overview
Table 60. Merck Measles Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 61. Merck Measles Vaccine Product
Table 62. Merck Recent Developments/Updates
Table 63. Novartis Corporation Information
Table 64. Novartis Description and Business Overview
Table 65. Novartis Measles Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 66. Novartis Measles Vaccine Product
Table 67. Novartis Recent Developments/Updates
Table 68. Pfizer Corporation Information
Table 69. Pfizer Description and Business Overview
Table 70. Pfizer Measles Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 71. Pfizer Measles Vaccine Product
Table 72. Pfizer Recent Developments/Updates
Table 73. Serum Institute of India Corporation Information
Table 74. Serum Institute of India Description and Business Overview
Table 75. Serum Institute of India Measles Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 76. Serum Institute of India Measles Vaccine Product
Table 77. Serum Institute of India Recent Developments/Updates
Table 78. China National Biotech Group Corporation Information
Table 79. China National Biotech Group Description and Business Overview
Table 80. China National Biotech Group Measles Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 81. China National Biotech Group Measles Vaccine Product
Table 82. China National Biotech Group Recent Developments/Updates
Table 83. Bavarian Nordic Corporation Information
Table 84. Bavarian Nordic Description and Business Overview
Table 85. Bavarian Nordic Measles Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 86. Bavarian Nordic Measles Vaccine Product
Table 87. Bavarian Nordic Recent Developments/Updates
Table 88. Emergent Biosolutions Corporation Information
Table 89. Emergent Biosolutions Description and Business Overview
Table 90. Emergent Biosolutions Measles Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 91. Emergent Biosolutions Measles Vaccine Product
Table 92. Emergent Biosolutions Recent Developments/Updates
Table 93. Medimmune Corporation Information
Table 94. Medimmune Description and Business Overview
Table 95. Medimmune Measles Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 96. Medimmune Measles Vaccine Product
Table 97. Medimmune Recent Developments/Updates
Table 98. Johnson & Johnson Corporation Information
Table 99. Johnson & Johnson Description and Business Overview
Table 100. Johnson & Johnson Measles Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 101. Johnson & Johnson Measles Vaccine Product
Table 102. Johnson & Johnson Recent Developments/Updates
Table 103. CSL Limited Corporation Information
Table 104. CSL Limited Description and Business Overview
Table 105. CSL Limited Measles Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 106. CSL Limited Measles Vaccine Product
Table 107. CSL Limited Recent Developments/Updates
Table 108. Production Base and Market Concentration Rate of Raw Material
Table 109. Key Suppliers of Raw Materials
Table 110. Measles Vaccine Distributors List
Table 111. Measles Vaccine Customers List
Table 112. Measles Vaccine Market Trends
Table 113. Measles Vaccine Growth Drivers
Table 114. Measles Vaccine Market Restraints
Table 115. Global Measles Vaccine Sales Forecast by Type (2022-2027) & (K MT)
Table 116. Global Measles Vaccine Sales Market Share Forecast by Type (2022-2027)
Table 117. Global Measles Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 118. Global Measles Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 119. Global Measles Vaccine Sales Forecast by Application (2022-2027) & (K MT)
Table 120. Global Measles Vaccine Sales Market Share Forecast by Application (2022-2027)
Table 121. Global Measles Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 122. Global Measles Vaccine Revenue Market Share Forecast by Application (2022-2027)
Table 123. Global Measles Vaccine Sales Forecast by Region (2022-2027) & (K MT)
Table 124. Global Measles Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 125. Global Measles Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 126. Global Measles Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Measles Vaccine
Figure 2. Global Measles Vaccine Market Share by Type in 2020 & 2027
Figure 3. Mumps Measles Rubella Vaccine, Live (MMR-II) Product Picture
Figure 4. Mumps Measles Rubella and Varicella Virus Vaccine (Proquad) Product Picture
Figure 5. Global Measles Vaccine Market Share by Application in 2020 & 2027
Figure 6. Children
Figure 7. Adults
Figure 8. Global Measles Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Measles Vaccine Market Size 2016-2027 (US$ Million)
Figure 10. Global Measles Vaccine Sales 2016-2027 (K MT)
Figure 11. Global Measles Vaccine Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. Measles Vaccine Sales Share by Manufacturers in 2020
Figure 13. Global Measles Vaccine Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest Measles Vaccine Players: Market Share by Revenue in 2020
Figure 15. Measles Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global Measles Vaccine Sales Market Share by Region (2016-2021)
Figure 17. Global Measles Vaccine Sales Market Share by Region in 2020
Figure 18. Global Measles Vaccine Revenue Market Share by Region (2016-2021)
Figure 19. Global Measles Vaccine Revenue Market Share by Region in 2020
Figure 20. U.S. Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Taiwan Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Philippines Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Vietnam Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. U.A.E Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Measles Vaccine by Type (2016-2021)
Figure 45. Sales Market Share of Measles Vaccine by Application (2016-2021)
Figure 46. Sales Market Share of Measles Vaccine by Application in 2020
Figure 47. Revenue Share of Measles Vaccine by Application (2016-2021)
Figure 48. Revenue Share of Measles Vaccine by Application in 2020
Figure 49. Manufacturing Cost Structure of Measles Vaccine
Figure 50. Manufacturing Process Analysis of Measles Vaccine
Figure 51. Measles Vaccine Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs